1. 1140. GATA2 Mutations Are Frequently Identified Among Patients With Myeloid Malignancies Who Develop Invasive Aspergillosis. (26th November 2018) Authors: Bold, Tyler D; Cheng, Matthew P; Vedula, Rahul S; Marty, Francisco M; Lindsley, R Coleman Journal: Open forum infectious diseases Issue: Volume 5(2018)Supplement 1 Page Start: S342 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 123. Oral Ibrexafungerp Outcomes by Fungal Disease in Patients from an Interim Analysis of a Phase 3 Open-label Study (FURI). (4th December 2021) Authors: Pappas, Peter G; Cornely, Oliver; Koehler, Philipp; McCarty, Todd P; Alexander, Barbara D; Miller, Rachel; Vazquez, Jose A; Sanders, John W; Morse, Caryn; Ostrosky-Zeichner, Luis; Krause, Robert; Prattes, Jürgen; Spec, Andrej; Rautemaa-Richardson, Riina; Bazaz, Rohit; Walsh, Thomas J; Marty, Fran... Journal: Open forum infectious diseases Issue: Volume 8(2021)Supplement 1 Page Start: S73 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 1248. Efficacy and Safety of Oral Ibrexafungerp in 41 Patients with Refractory Fungal Diseases, Interim Analysis of a Phase 3 Open-label Study (FURI). (31st December 2020) Authors: Alexander, Barbara D; Cornely, Oliver; Pappas, Peter; Miller, Rachel; Vazquez, Jose A; Ostrosky-Zeichner, Luis; Spec, Andrej; Rautemaa-Richardson, Riina; Krause, Robert; Thompson III, George R; Morse, Caryn; Sanders, John W; Andes, David; Andes, David; Lyon, George; Marty, Francisco M; Silverman,... Journal: Open forum infectious diseases Issue: Volume 7:Number 1(2020) Supplement Page Start: S642 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 1399. Clarithromycin–Rifampin-based Treatment for Non-tuberculous Mycobacterial Infections in Immunocompromised Patients Who Require Concomitant CYP-Metabolized Medications. (4th December 2021) Authors: Gonzalez-Bocco, Isabel H; Aleissa, Muneerah M; Cheng, Matthew; Manne-Goehler, Jennifer; Marty, Francisco M Journal: Open forum infectious diseases Issue: Volume 8(2021)Supplement 1 Page Start: S784 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 147. Identification of Novel Colistin Resistance Genes in an Extremely Colistin Resistant Pseudomonas aeruginosa Clinical Isolate. (15th December 2022) Authors: Gatesy, Samuel W; Bertucci, Hanna; Vessely, Madeleine; Vessely, Madeleine; Valdes, Aliki; Alisoltanidehkordi, Arghavan; Ozer, Egon A; Marty, Francisco M; Mekalanos, John; Hauser, Alan R; Bachta, Kelly E R Journal: Open forum infectious diseases Issue: Volume 9:(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 1557. Acyclovir-Resistant (ACV-R) Herpes Simplex Virus (HSV) Disease in Patients with Hematologic Malignancies (HM) and Hematopoietic-Cell Transplant (HCT) Recipients. (26th November 2018) Authors: Pandit, Alisha; Cheng, Matthew P; Liakos, Alexis; Treister, Nathaniel; Baden, Lindsey R; Issa, Nicolas C; Marty, Francisco M; Hammond, Sarah P Journal: Open forum infectious diseases Issue: Volume 5(2018)Supplement 1 Page Start: S484 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 1564. Lower Rates of Epstein–Barr Virus (EBV) Viremia in Pediatric Solid Organ Transplant (SOT) Recipients Who Received Valganciclovir Prophylaxis. (26th November 2018) Authors: Moulton, Elizabeth A; Karandikar, Manjiree; Bond, Sheila; Burchett, Sandra; Sharma, Tanvi; Marty, Francisco M Journal: Open forum infectious diseases Issue: Volume 5(2018)Supplement 1 Page Start: S487 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. 1576. Risk of Clinical Tuberculosis (TB) Among Patients with Latent TB Infection (LTBI) Who Undergo Allogeneic Hematopoietic-Cell Transplantation (HCT). (26th November 2018) Authors: Kusztos, Amanda E; Cheng, Matthew P; Bold, Tyler D; Ho, Vincent T; Glotzbecker, Brett E; Hsieh, Candace; Baker, Meghan A; Hammond, Sarah P; Baden, Lindsey R; Marty, Francisco M Journal: Open forum infectious diseases Issue: Volume 5(2018)Supplement 1 Page Start: S492 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. 1715. A Randomized, Double-Blind, Placebo-Controlled Multicenter Phase 2 Trial to Examine the Effects of DAS181 in Immunocompromised (IC) Patients With Parainfluenza Virus (PIV) Lower Respiratory Tract Infection (LRTI) on Supplemental Oxygen (SO). (26th November 2018) Authors: Chemaly, Roy F; Moss, Ronald; Marty, Francisco M; Wolfe, Cameron R; Lawrence, Steven J; Dadwal, Sanjeet; Soave, Rosemary; Hwang, Jimmy; Hawley, Stephen; Routh, Rebecca; Ho, Jennifer; Wang, George; Chang, Nancy; Boeckh, Michael Journal: Open forum infectious diseases Issue: Volume 5(2018)Supplement 1 Page Start: S50 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. 1730. Outcomes of Patients With Detectable Cytomegalovirus (CMV) DNA at Randomization in the Double-blind, Placebo-Controlled Phase 3 Trial of Letermovir (LET) Prophylaxis for CMV-Seropositive Allogeneic Hematopoietic-Cell Transplantation (HCT) Recipients. (26th November 2018) Authors: Marty, Francisco M; Ljungman, Per; Chemaly, Roy F; Wan, Hong; Teal, Valerie L; Butterton, Joan; Yeh, Wendy W; Leavitt, Randi Y; Badshah, Cyrus Journal: Open forum infectious diseases Issue: Volume 5(2018)Supplement 1 Page Start: S56 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗